NCT07620470 Spectral Precise Image Study for Brain Tumors
| NCT ID | NCT07620470 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Philips Clinical & Medical Affairs Global |
| Condition | Brain Tumors |
| Study Type | OBSERVATIONAL |
| Enrollment | 120 participants |
| Start Date | 2025-11-28 |
| Primary Completion | 2026-08-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 120 participants in total. It began in 2025-11-28 with a primary completion date of 2026-08-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to explore the image quality of spectral CT deep learning reconstruction technology (Spectral Precise Image) of patients with confirmed brain tumors. The main question it aims to answer is: The Image Quality (IQ) and diagnostic confidence of Spectral Precise Image reconstructions
Eligibility Criteria
Inclusion Criteria: 1. Patients with clinical and radiology (MRI/CT) diagnosed brain tumors. 2. Patients who underwent contrast enhanced scans using the Spectral CT 7500. 3. Study participants with age ≥ 18 years old. 4. Study participants that have signed Informed Consent Form (ICF) Exclusion Criteria: 1. The clinical data or radiological information is considered incomplete after evaluation by the investigator. 2. Study participant that was enrolled in this study in the past 3. Data from study participants deemed unsuitable for enrollment based on the investigator's evaluation
Contact & Investigator
Jing Wang
PRINCIPAL INVESTIGATOR
1277 Jiefang Avenue, Wuhan, Hubei Province, P. R. China
Frequently Asked Questions
Who can join the NCT07620470 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Brain Tumors. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07620470 currently recruiting?
Yes, NCT07620470 is actively recruiting participants. Contact the research team at xhwangjing@hust.edu.cn for enrollment information.
Where is the NCT07620470 trial being conducted?
This trial is being conducted at Wuhan, China.
Who is sponsoring the NCT07620470 clinical trial?
NCT07620470 is sponsored by Philips Clinical & Medical Affairs Global. The principal investigator is Jing Wang at 1277 Jiefang Avenue, Wuhan, Hubei Province, P. R. China. The trial plans to enroll 120 participants.